Page 7 - Solution Group Bhd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

KUALA LUMPUR (Jan 12): Promising developments on the vaccine front have stirred investor interest in companies that venture into vaccine distribution, in hopes they will be in for bumper profits. However, it is not clear at this juncture just how much or when these companies can cash in, given just the evaluation process alone for a vaccine to be approved for distribution and use in Malaysia will take five phases. The first phase alone — which is the checking of the vaccine dossiers or research documents — typically takes between 90 and 120 days, according to the Ministry of Health (MoH)....

IF 2020 is the year of rubber glove manufacturers and technology-related counters, penny stocks deserve at least a notable mention. The penny stock fever on the local bourse has not been seen for at least 20 years since the dotcom bubble burst. The eye-popping share price rally lured long-absent retail investors to the stock market and that, in turn, lifted the daily trading volume to a record high of 27.8 billion shares on Aug 11. At the height of the penny stock fever in August, share prices hitting limit up were not a rare sight. On Aug 7, 12 stocks hit limit up, including HLT Global Bhd,�...

AHEAD of an anticipated mass roll-out of Covid-19 vaccines in Malaysia next year, private sector players are positioning themselves to fill any gaps in the vaccine supply chain, notwithstanding Putrajaya’s supply arrangement with Pfizer and the Covid-19 vaccine global access (COVAX) facility. Comments by Minister of Science, Technology and Innovation Khairy Jamaluddin that vaccine arrangements by private companies are purely commercial deals and not related to the government have not dimmed private sector interest in the Covid-19 vaccine supply. Local companies that have jumped onto the ban...

Bhd are companies leading the charge in the race to supply the Covid-19 vaccine to 32.7 million Malaysians. Both have fill and finish facilities that have been approved by the National Pharmaceutical Regulatory Authority (NPRA) and are tipped to handle the supply of vaccines that the government purchases. The priority list for the government is the frontliners and the elderly who are most at risk. That leaves quite a number of people who would want to be inoculated and likely to seek the vaccine from the private healthcare system. Seizing the opportunity, there are also a host of companies w...

IT was a watershed moment when an elderly 91-year-old woman from the UK received the first Covid-19 vaccine injection. Her inoculation symbolises the need to protect the vulnerable given the susceptibility of the elderly to the disease. It also shows the willingness to receive the jab that will allow everyone to get on with their lives in resuming the old normal in an increasingly new normal world. Margaret Keenan’s vaccination was made possible after the UK government approved the Pfizer-BioNTech vaccine that broke all records in terms of approvals from the health authorities. The race to ...